Showing results (151-160 of 224) with videos related to
Sort By:
Pageof 23
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 24, 2017
Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF studyCarsten Bokemeyer, Pere Gascón, Matti Aapro, et al.Chest|March 31, 2020
OSA and Neurocognitive Impairment in Children With Congenital Heart DiseaseDaniel Combs, Jamie O Edgin, Scott Klewer, et al.BMC Nephrology|March 7, 2019
Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 studyChristian Combe, Johannes Mann, David Goldsmith, et al.Critical Reviews in Oncology/Hematology|March 2, 2010
Background and methodology of MONITOR-GCSF, a pharmaco-epidemiological study of the multi-level determinants, predictors, and clinical outcomes of febrile neutropenia prophylaxis with biosimilar granulocyte-colony stimulating factor filgrastimPere Gascón, Matti Aapro, Heinz Ludwig, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|July 27, 2019
Real-World Evidence from the Integrative Medicine Primary Care Trial (IMPACT): Assessing Patient-Reported Outcomes at Baseline and 12-Month Follow-UpRobert L Crocker, Jason T Hurwitz, Amy J Grizzle, et al.BMC Complementary and Alternative Medicine|November 17, 2017
Integrative medicine primary care: assessing the practice model through patients' experiencesRobert L Crocker, Amy J Grizzle, Jason T Hurwitz, et al.Clinical Nephrology|November 24, 2017
Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study
Gérard London, Johannes Mann, David Goldsmith, et al.Blood|October 30, 2016
Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United StatesAhmed Aljabri, Yvonne Huckleberry, Jason H Karnes, et al.The Annals of Pharmacotherapy|April 9, 2009
Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study)Patricia Van der Niepen, Annemie Woestenburg, Heidi Brié, et al.Journal of Geriatric Oncology|November 11, 2016
Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study)Matti Aapro, Carsten Bokemeyer, Heinz Ludwig, et al.Pageof 23